a few questions

Just wondering a few things...  Anyone here know where we stand on the prove 3 trials?  What's the concensus now that we have a lot of data in on telapravir?  At my last appt about 6 months ago the PA talked like telapravir was the silver bullet.  I'm 1b and have been through two trials (high-dose inf and riba + inf) and one regular treatment last year (peg + riba).  Never cleared and each successive treatement has been worse.  It must be the riba cause the inf only treatment was a fairly easy compared to the ones with riba.  Anyway what's the success rate with telapravir for 1b non-responders.  I figure I can't do another trial unless I know I'm getting something new such as telapravir.  What comes after prove 3?  Also does "SOC" stand for standard of care, i.e., rib + peg.  I've got an appt in January so I hope they can tell me something good.  regards, David